Republican Sen. Chuck Grassley is demanding answers from a key drug company on why the vital allergic medication EpiPen has increased by more than $500 in some cases.
The Iowa senator wrote a letter to the CEO of Mylan, which distributes the drug, to ask why the “much-needed medication” has seen an increase in price. He asked about whether the company offers any patient assistance programs for providing the drug, and singled out help given to schools.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.